Search results for: 'cell ad g01e therapy cold chain'
- Related search terms
- cell biology research market global 2014 2014
- cell biolog research market global 2014 2030
- cell biolog research market global 2014 2020
- cell biolog research market global 2030 2030
- cell biolog research market global 2014 2024
-
24 Oct 2024  |  Global  |  Market Research
Evolution of EV Batteries by Cell Type (Prismatic, Pouch, Cylindrical), Forecast to 2030
Prismatic EV Batteries will Experience Transformational Growth by 2030. Pouch Cells will Gain Popularity, Driven by the Growing Adoption of Solid-state Batteries.
Global demand for electric vehicle (EV) batteries is surging, driven by the rapid growth of EVs and the increasingly stringent environmental regulations. In response, the industry is experiencing a transformative shift, with advancements in battery formats, chemistries, and structural designs. Cylindrical, prismatic, and pouch cells—each with uniqu...
$4,950.00
Special Price $4,207.50 save 15 %
-
12 Jan 2024  |  Global  |  Market Research
Emerging Innovations and Future Growth Opportunities in Bifacial Solar Cells
Maximizes Solar Energy Potential in Low-light Environments
Solar energy constituted 65% of the total 295 GW installed renewable capacity in 2022. About 70% of the deployed solar panels were monofacial panels that generate electricity from only the top side of the panel. Despite their popularity, these monofacial panels have encountered challenges related to space efficiency, energy yield, and dependence on...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
07 Nov 2024  |  Global  |  Market Research
Global Supply Chain Reorientation and Transformative Shifts, 2024 2026
Local Partnerships, Vertical Integration, and Cross-border Collaboration are Emerging as the Top Strategies for Supply Chain Reorientation
This Frost & Sullivan analysis examines the realignment of global supply chains toward localization, regionalization, and diversification beyond China. Supply chain reorientation gained momentum after the pandemic and has continued to gather pace as companies seek to insulate themselves from increasing geopolitical and economic risks. Businesses ar...
$2,450.00
Special Price $2,082.50 save 15 %
-
05 Aug 2024  |  Global  |  Technology Research
CGT Research Outlook and Technology Growth Opportunities
CGT Landscape Assessment
The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...
$4,950.00
Special Price $4,207.50 save 15 %
-
17 Sep 2024  |  Global  |  Market Research
ADAS and AD Sensor Suite Strategies, Europe, 2024 2030
OEMs Strategies Will Drive Transformational Growth by Using LiDAR as a Primary Sensor with Cameras and Imaging Radar to Meet the Rise of Eyes-off Driving
The global automotive industry is going through a transformation with the convergence of the connected, autonomous, shared, and electric (CASE) trends. Connectivity and autonomous driving (AD) features are leading this transformation. Globally, OEMs are looking to introduce various advanced driver assistance system (ADAS) features ranging from L0 t...
$4,950.00
Special Price $4,207.50 save 15 %
-
22 Dec 2023  |  Global  |  Market Research
Global Water Treatment Chemicals Industry: Supply Chain Resilience
Raw Materials Innovation and Value Chain Collaboration are Prominent Strategies in Building Resilience in Water Treatment Chemicals Supply
Water treatment chemicals play a significant role in water pre-treatment for municipal and industrial use and the treatment of municipal and industrial wastewater for environmentally safe disposal. The growing popularity of chemical-based mobile water treatment services, installation of zero liquid discharge and minimal liquid discharge infrastruct...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2020  |  North America  |  Market Research
Server-Side Ad Stitching Finds a Home in Live and Catch-Up
Server-Side Ad Stitching in Live and Catch-Up
Server-side ad insertion has normally been about tackling the problems of ad blocking and device fragmentation. But the industry is now seeing platform shifts that change the sweet spot of ad stitching towards live and catch-up TV. Client-side ad SDKs have grown in sophistication, the platforms they run have become more capable and the transition t...
$1,500.00
Special Price $1,125.00 save 25 %
-
11 Jan 2017  |  North America  |  Market Research
Global Cell Banking Market Trends, Opportunities, and Future
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %